Stroke Research

Stroke is classified as both a neurological and a cardiovascular disease, as it is a disruption in blood supply to the brain which causes the neurological abnormalities. There are two types of stroke; ischemic and hemorrhagic.

Stroke Research Products Targets

Products for Stroke Research - Page 37

Cat.No. Product Name Information/Activity
BCN2571 L-Theanine L-Theanine (L-Glutamic Acid γ-ethyl amide）is a non-protein amino acid contained in green tea leaves, which blocks the binding of L-glutamic acid to glutamate receptors in the brain, and with neuroprotective and anti-oxidative activities. L-Theanine causes anti-stress effects via the inhibition of cortical neuron excitation by oral intake.
BCC2512 Zonisamide Zonisamide is a 1,2 benzisoxazole derivative and the first agent of this chemical class to be developed as an antiepileptic drug.
BCC6746 L-Canavanine sulfate L-Canavanine sulfate is a selective inhibitor of inducible NO synthase.
BCC2865 L-NAME hydrochloride L-NAME hydrochloride inhibits NOS with an IC50 of 70 μM. L-NAME is a precursor to NOS inhibitor L-NOARG which has an IC50 value of 1.4 μM.
BCC5674 7-NINA 161467-34-1
BCC6713 7-Nitroindazole 2942-42-9
BCC6788 L-NMMA acetate L-NMMA acetate is a nitric oxide synthase inhibitor of all NOS isoforms including NOS1, NOS2, and NOS3. The Ki values for nNOS (rat), eNOS (human), and iNOS (mouse) are approximately 0.18, 0.4, and 6 µM, respectively.
BCC2864 H-Arg(NO2)-OH 2149-70-4
BCC6847 TRIM 25371-96-4
BCC6566 cis-ACPD 477331-06-9